Literature DB >> 32109157

Surgical Trends in Breast Cancer in Turkey: An Increase in Breast-Conserving Surgery.

Güldeniz Karadeniz Çakmak1, Selman Emiroğlu2, Atakan Sezer3, Nuh Zafer Canturk4, Levent Yeniay5, Bekir Kuru6, Hasan Karanlık7, Aykut Soyder8, Şehsuvar Gökgöz9, Gürhan Sakman10, Muhammed Ucuncu11, Mufide Nuran Akcay12, Sadullah Girgin13, Sibel Ozkan Gurdal14, Mustafa Emiroglu15, Serdar Ozbas16, Abdullah Bahadir Öz17, Cumhur Arici18, Osman Toktas19, Orhan Demircan20, Adnan Çalık21, Ayfer Kamali Polat6, Gokturk Maralcan22, Seher Demirer23, Vahit Ozmen2.   

Abstract

PURPOSE: Breast cancer is the most frequent cancer in women, and there is a great variability in surgical practice for treating that cancer in different countries. The aims of this study were to analyze the effect of guidelines from the Turkish Federation of Breast Diseases Societies on academic institutions that have breast centers and to evaluate surgical practice in Turkey in 2018. PATIENTS AND METHODS: Between January and March 2019, a survey was sent to breast surgeons who were working in breast centers in academic institutions. The sampling frame included 24 academic institutions with breast centers in 18 cities in Turkey to evaluate interdisciplinary differences among breast centers and seven regions in Turkey regarding patients' choices, surgical approaches, and academic institutions.
RESULTS: All surgeons responded to the survey, and all 4,381 patients were included. Most of the surgeons (73.9%) were working in a breast center. Multidisciplinary tumor boards were performed in 87% of the breast centers. The average time between clinical evaluation and initiation of treatment was 29 days; the longest time was in Southeast Anatolia (66 days). Only 6% of patients had ductal carcinoma in situ. Sentinel lymph node biopsy was available in every region across the country and was performed in 64.5% of the patients. In 2018, the overall breast-conserving surgery rate was 57.3% in Turkey, and it varied from 72.2% in the Black Sea region to 33.5% in Central Anatolia (P < .001). Oncoplastic breast surgery options were available at all breast centers. However, 25% of the breast centers from the Black Sea region and half the breast centers from Eastern Anatolia and the Mediterranean region did not perform this type of surgery.
CONCLUSION: Increasing rates of nonpalpable breast cancer and decreasing rates of locoregional recurrences favored breast-conserving surgery, especially in developed countries. Guidelines from the Turkish Federation of Breast Diseases Societies resulted in more comprehensive breast centers and improved breast health in Turkey.

Entities:  

Mesh:

Year:  2020        PMID: 32109157      PMCID: PMC7051798          DOI: 10.1200/JGO.19.00275

Source DB:  PubMed          Journal:  JCO Glob Oncol        ISSN: 2687-8941


  30 in total

1.  Variation in management of early breast cancer in the Netherlands, 2003-2006.

Authors:  L N van Steenbergen; L V van de Poll-Franse; M W J M Wouters; M L E A Jansen-Landheer; J W W Coebergh; H Struikmans; V C G Tjan-Heijnen; C J H van de Velde
Journal:  Eur J Surg Oncol       Date:  2010-09       Impact factor: 4.424

2.  Breast Cancer in Turkey: Clinical and Histopathological Characteristics (Analysis of 13.240 Patients).

Authors:  Vahit Özmen
Journal:  J Breast Health       Date:  2014-04-01

3.  Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial.

Authors:  Mila Donker; Geertjan van Tienhoven; Marieke E Straver; Philip Meijnen; Cornelis J H van de Velde; Robert E Mansel; Luigi Cataliotti; A Helen Westenberg; Jean H G Klinkenbijl; Lorenzo Orzalesi; Willem H Bouma; Huub C J van der Mijle; Grard A P Nieuwenhuijzen; Sanne C Veltkamp; Leen Slaets; Nicole J Duez; Peter W de Graaf; Thijs van Dalen; Andreas Marinelli; Herman Rijna; Marko Snoj; Nigel J Bundred; Jos W S Merkus; Yazid Belkacemi; Patrick Petignat; Dominic A X Schinagl; Corneel Coens; Carlo G M Messina; Jan Bogaerts; Emiel J T Rutgers
Journal:  Lancet Oncol       Date:  2014-10-15       Impact factor: 41.316

Review 4.  Understanding of regional variation in the use of surgery.

Authors:  John D Birkmeyer; Bradley N Reames; Peter McCulloch; Andrew J Carr; W Bruce Campbell; John E Wennberg
Journal:  Lancet       Date:  2013-09-28       Impact factor: 79.321

Review 5.  Breast cancer: a review for the general surgeon.

Authors:  Cindy B Matsen; Leigh A Neumayer
Journal:  JAMA Surg       Date:  2013-10       Impact factor: 14.766

Review 6.  The Changing Paradigms for Breast Cancer Surgery: Performing Fewer and Less-Invasive Operations.

Authors:  David W Ollila; E Shelley Hwang; David R Brenin; Henry M Kuerer; Katharine Yao; Sheldon Feldman
Journal:  Ann Surg Oncol       Date:  2018-07-02       Impact factor: 5.344

7.  Breast Cancer in Turkey; An Analysis of 20.000 Patients with Breast Cancer.

Authors:  Vahit Özmen; Tolga Özmen; Volkan Doğru
Journal:  Eur J Breast Health       Date:  2019-07-01

8.  Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women.

Authors:  Eileen M Kesson; Gwen M Allardice; W David George; Harry J G Burns; David S Morrison
Journal:  BMJ       Date:  2012-04-26

9.  Income level and regional policies, underlying factors associated with unwarranted variations in conservative breast cancer surgery in Spain.

Authors:  Manuel Ridao-López; Sandra García-Armesto; Begoña Abadía-Taira; Salvador Peiró-Moreno; Enrique Bernal-Delgado
Journal:  BMC Cancer       Date:  2011-04-19       Impact factor: 4.430

10.  Factors affecting breast cancer treatment delay in Turkey: a study from Turkish Federation of Breast Diseases Societies.

Authors:  Vahit Ozmen; Sukru Boylu; Engin Ok; Nuh Zafer Canturk; Varol Celik; Murat Kapkac; Sadullah Girgin; Mustafa Tireli; Enver Ihtiyar; Orhan Demircan; Mazhar Semih Baskan; Ayhan Koyuncu; Ismet Tasdelen; Esra Dumanli; Fatih Ozdener; Piotr Zaborek
Journal:  Eur J Public Health       Date:  2014-08-05       Impact factor: 3.367

View more
  1 in total

1.  Survival Rate and Prognostic Factors in Turkish Women Patients with Breast Cancer.

Authors:  Şebnem Zorlutuna
Journal:  Iran J Public Health       Date:  2022-02       Impact factor: 1.479

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.